Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

HomeNewsAntiplatelet drug

Antiplatelet Drug

Jump to

Aurobindo gains 2.5% on USFDA approval for 2 drugs

Aurobindo on Wednesday has received final approvals from the US Food & Drug Administration (USFDA) to manufacture & market Eptifibatide injection and Levonorgestrel tablet.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347